We continue using multiparameter sorting and analysis with the fluorescence activated cell sorter (FACS) to define functionally and clinically relevant lymphocyte subpopulations in mouse and man and select variant and DNA-transformed animal cell lines for recombinant DNA analyses of the genes and genetic mechanisms controlling the structure and production of immunologically relevant molecules. Thus, we plan to: (1) Extend our library of immunoglobulin constant-region (IgCH) """"""""switch-variant"""""""" families derived from hybridoma cell lines by selecting interchromosomal and interspecies (mouse-human) variants producing """"""""chimeric"""""""" antibodies, variants producing modified parental IgCH structures, and regulatory variants showing changes in the expression of parental IgCH genes. We will then investigate the genetic mechanisms underlying these """"""""IgCH switches"""""""" by testing for mutations, rearrangements, somatic cross-overs, or other chromosomal changes; methylation or other DNA modifications affecting transcription; or differential splicing of primary transcripts or other mechanisms affecting translation. (2) Transform with DNA to obtain cell lines secreting or carrying gene products derived from a different species or haplotype. We hope to obtain transformants for genes expressed in differentiated lymphocytes, e.g., mouse Lyt-1 and Lyt-2 and their human homologs (Leu-1 and Leu-2). (3) Define B- and T-cell subpopulations in mouse and man according to correlated surface-marker expression and investigate the genetic mechanisms influencing the expression of surface markers, secreted products, and differentiation-specific mRNAs in FACS-isolated T- and B-cell subpopulations. We have obtained (1) transformants expressing some ten different human antigens or receptor molecules including Leu 1, Leu 2, HLA, Beta 2 microglobulin, nerve growth factor receptor, and transferrin receptor and (2) a number of transformants expressing mouse molecules including Ly-1, Lyt-2, L3T4, several B-cell specific antigens, and IgG-Fc receptor. Using the FACS, we selected amplified cell lines making Leu 2 and its putative mouse homolog, Lyt-2. Using these lines and several molecular biology methods, most notably selected cDNA probes, we cloned the genes for each of these molecules. We have now obtained the nucleotide sequences of these genes, confirmed their genetic homologym, and begun our structure-function correlation studies. An interesting surprise is that these genes are new members of the immunoglobulin gene super family with closest homology to IgV regions. (CS)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA004681-26
Application #
3163183
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1977-09-30
Project End
1988-01-31
Budget Start
1985-02-01
Budget End
1986-01-31
Support Year
26
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Dangl, J L; Wensel, T G; Morrison, S L et al. (1988) Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J 7:1989-94
Hagiwara, H; Huang, H J; Arai, N et al. (1987) Interleukin 1 modulates messenger RNA levels of lymphokines and of other molecules associated with T cell activation in the T cell lymphoma LBRM33-1A5. J Immunol 138:2514-9
Huang, H J; Jones, N H; Strominger, J L et al. (1987) Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to its human counterpart Leu-1/T1 (CD5). Proc Natl Acad Sci U S A 84:204-8
Nakauchi, H; Tagawa, M; Nolan, G P et al. (1987) Isolation and characterization of the gene for the murine T cell differentiation antigen and immunoglobulin-related molecule, Lyt-2. Nucleic Acids Res 15:4337-47
Hardy, R R; Dangl, J L; Hayakawa, K et al. (1986) Frequent lambda light chain gene rearrangement and expression in a Ly-1 B lymphoma with a productive kappa chain allele. Proc Natl Acad Sci U S A 83:1438-42
Kleinfield, R; Hardy, R R; Tarlinton, D et al. (1986) Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. Nature 322:843-6
Kipps, T J; Herzenberg, L A (1986) Homologous chromosome recombination generating immunoglobulin allotype and isotype switch variants. EMBO J 5:263-8
Herzenberg, L A; Stall, A M; Lalor, P A et al. (1986) The Ly-1 B cell lineage. Immunol Rev 93:81-102
Tagawa, M; Nakauchi, H; Herzenberg, L A et al. (1986) Formal proof that different-size Lyt-2 polypeptides arise from differential splicing and post-transcriptional regulation. Proc Natl Acad Sci U S A 83:3422-6
Hayakawa, K; Hardy, R R; Herzenberg, L A (1986) Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur J Immunol 16:450-6

Showing the most recent 10 out of 16 publications